Dr. Bree is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030
Summary
- Dr. Kelly Bree is an urologic oncologist in Houston, TX and is affiliated with University of Texas M.D. Anderson Cancer Center. She received her medical degree from George Washington University School of Medicine and has been in practice 2 years. She specializes in surgical management of kidney, bladder and prostate cancers. She has more than 20 peer-reviewed articles and book chapters.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2020 - 2022
University of California (San Diego) Medical CenterResidency, Surgery, 2014 - 2019
George Washington University School of Medicine and Health SciencesClass of 2014
Certifications & Licensure
TX State Medical License 2020 - 2025
CA State Medical License 2016 - 2023
Awards, Honors, & Recognition
- Physicians Referral Service Top Performer (Top 10th percentile nationally) 2023
Clinical Trials
- Intravesical BCG vs GEMDOCE in NMIBC Start of enrollment: 2023 Feb 07
- A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT Start of enrollment: 2023 Dec 14
Publications & Presentations
PubMed
- 4 citationsBladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Se...Roger Li, Patrick J Hensley, Shilpa Gupta, Hikmat Al-Ahmadie, Marko Babjuk
European Urology. 2024-12-01 - Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer.Patrick Carriere, Omar Alhalabi, Jianjun Gao, Osama Mohamad, Matthew T Campbell
Clinical and Translational Radiation Oncology. 2024-11-01 - 1 citationsSex Disparity in Non-muscle-invasive Bladder Cancer: Pitfalls of Large Population-based Data Sets and Lessons from an Integrated Analysis.Niyati Lobo, Zhigang Duan, Akshay Sood, Hui Zhao, Sia V Lindskrog
European Urology Oncology. 2024-10-23
Press Mentions
Study Charts Uptick in Unnecessary CT, MR Imaging Surveillance of Noninvasive Bladder CancerMarch 21st, 2022
Overuse of Surveillance in Bladder Cancer, Despite GuidelinesSeptember 6th, 2022
Risk Stratification Examined for High-Grade Ta Bladder TumorsSeptember 6th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
